Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 109 | SFEBES2025 | Next issue

Society for Endocrinology BES 2025

Harrogate, UK
10 Mar 2025 - 12 Mar 2025

Card image cap
SfE BES is the UK's leading endocrinology meeting. It will return to Harrogate in 2025.

Oral Communications

Endocrine Cancer and Late Effects

Previous section
Bone and Calcium
Table of contents
Next section
Reproductive and Neuroendocrinology

ea0109oc2.1 | Endocrine Cancer and Late Effects

Glutamine antagonism as a new treatment approach in adrenocortical carcinoma

ea0109oc2.2 | Endocrine Cancer and Late Effects

The androgen mediated interplay between cytoplasmic AR and G3BP1 as a driver of endocrine therapy resistance in breast cancer

ea0109oc2.3 | Endocrine Cancer and Late Effects

Serum untargeted metabolomics reveals widespread metabolic dysregulation in adrenocortical carcinoma

ea0109oc2.4 | Endocrine Cancer and Late Effects

The development of humanised 3D bioprinted models of endocrine resistant breast cancer

ea0109oc2.5 | Endocrine Cancer and Late Effects

Adrenal masses differentiation through the measurement of circulating cell-free DNA concentrations

ea0109oc2.6 | Endocrine Cancer and Late Effects

Combinatorial drug strategy targeting sodium iodide symporter (NIS) activity enhances radionuclide uptake in breast and thyroid settings in vivo

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more